Provides dual-function anti-aging and skin-brightening synergy, combining adenosine's A2A receptor-mediated collagen support with niacinamide's melanosome-blocking and ceramide-supporting activity.
Read the passport아데노신 · 전성분
Adenosine
A naturally occurring purine nucleoside and endogenous cell-signaling molecule that binds A2A cell-surface receptors on dermal fibroblasts to stimulate collagen synthesis, reduce expression wrinkles, and restore skin elasticity 1,2.
GentlenessNot yet scored See how we verify EvidenceIndicativeTopicalTopical or procedure-assisted (microneedle-assisted)
- INCI
- ADENOSINE
Also called Adenosin · 9-beta-D-Ribofuranosyladenine · Adenine Riboside
Early-stage page
This ingredient page is still early. We're actively researching before it's ready to stand fully on its own — check back as more sections are verified.
The short answer
Four lines, each compressed from the section it links to. Every line carries the sources of the claim it compresses.
- What it does
Visible Wrinkle Reduction and Expression Line Smoothing
See the evidence - Where it goes
moisturizer or serum step · day and night
See how to use it - What shows, and when
4 weeks: Visible reduction in fine surface lines around the eyes and forehead, with improved skin elasticity and firmness 1.
Source1
See the timeline
How to use it
Where it sits in the seven-step ladder, and the record's own fields for the habit.
아침DayDay: used
저녁NightNight: used
day and night
Cleanser클렌저
Toner토너
Essence에센스
Serum세럼 sits here
Eye cream아이크림
Moisturizer크림 sits here
Sunscreen자외선차단제
Filled steps are where Adenosine commonly appears. No product is recommended.
Everything here comes from the sources below. None of it is a product recommendation.
- Time of day
- day and night
- Where it sits
- moisturizer or serum step
- Starting frequency
- daily
- Amount
- pea-sized amount or 1-2 pumps of serum
- Application
- Apply evenly to clean, dry skin on the face, neck, and eye area. Gently pat with fingertips to encourage absorption. Safe to layer alongside all other active skincare ingredients.
- Storage
- Store in a cool, dry place away from direct heat and light. Keep container tightly sealed.
Plays well with / keep apart
One card per pair. Where the partner has its own passport, the name links to it.
Do layer it with
Synergistically amplifies dermal extracellular matrix remodeling, pairing peptide signal transduction with nucleoside A2A receptor-mediated neocollagenesis.
What to expect, and when
The record's own timeline. Each step keeps the source of the study it came from.
- Immediate
Initial skin conditioning, hydration, and softening of skin texture.
- 4 weeks
Visible reduction in fine surface lines around the eyes and forehead, with improved skin elasticity and firmness 1.
Source1
- 8 weeks
Clinically proven reduction in periorbital crow's feet and glabellar frown lines, measurable improvement in dermal density, and smoother overall facial contour 1,4.
Is this safe for me
Everything the record says about suitability, consolidated. Pause-first comes first.
Before you start
Exceptionally gentle and non-irritating on all skin types; can be used daily without risk of photosensitivity or barrier disruption.
Good match for
An endogenous nucleoside accepted readily by even the most sensitive, reactive, or post-procedure skin barriers, with zero known photosensitivity.
Best match
wrinkles and fine lines
aging skin · loss of elasticity · sensitive skin
Routine
moisturizer or serum step
Pregnancy and breastfeeding
Not medical advice · ask your own clinician
Pregnancy. A 2011 dermatology review of skin-care product safety in pregnancy names hydroquinone (high systemic absorption) and tretinoin (evidence controversial) as the actives of concern, and states that most other topical skin-care products act locally and produce minimal systemic absorption; adenosine is not named among the flagged concerns 5. This is general topical-product reasoning rather than an ingredient-specific safety trial. If you are pregnant, ask your doctor before use.
Breastfeeding. Topical application is applied locally with minimal expected systemic absorption; no ingredient-specific breastfeeding safety trial was located. As a general precaution common to topical actives, avoid applying directly to the breast or nipple area, since incidental transfer to a nursing infant has not been studied for this ingredient. If you are breastfeeding, ask your doctor before use.
| Common, and it usually settles | Stop using it |
|---|---|
| A soothing, comfortable feeling upon application with no stinging, flaking, or photosensitivity. | persistent redness |
| localized itching | |
| allergic rash |
Allergen history
A dedicated search of the peer-reviewed literature (PubMed) for adenosine topical allergic contact dermatitis, contact allergy, sensitization, and contraindication case reports found none. This is consistent with, though not proven by, the ingredient's own clinical trial record: every verified clinical source for this record reports no adverse events within its own trial population 1,4.
Who should not use it
Not yet researched
Research in progress — check back soon. How we verify
What it will not do
- The 0.04% to 0.1% clinical anti-wrinkle improvements demonstrated in leave-on creams cannot be expected from rinse-off cleansers due to negligible contact time.
- The receptor-mediated collagen stimulation achieved by topical adenosine cannot match the immediate paralytic line-freezing effect of injectable botulinum neurotoxin.
The evidence
One card per claim. Concentration, form, population and limitation sit with it, always visible.
Grade legend
- Indicative
- Limited
- Moderate
- Strong
Visible Wrinkle Reduction and Expression Line Smoothing
IndicativeVisibly reduces periorbital lines (crow's feet), glabellar frown lines, and skin surface roughness while improving skin smoothness and firmness.1
- Tested concentration
- 0.04% to 0.1%
- Which form
- Pure Bio-Fermented Adenosine
- Population and duration
- 126 female volunteers aged 45-65 applying adenosine cream vs placebo twice daily for 8 weeks
- Limitation
- Delivers gradual, cumulative structural improvements over 3 to 8 weeks rather than instant muscle-paralyzing outcomes seen with neurotoxin injections.
Stimulation of Type I and Type III Dermal Collagen Synthesis
IndicativeStimulates dermal fibroblasts to synthesize type I and type III procollagen, rebuilding extracellular matrix support and increasing dermal density.2,4
- Tested concentration
- physiologically active concentration (nanomolar to micromolar range)
- Which form
- Pure Bio-Fermented Adenosine
- Population and duration
- Primary normal human dermal fibroblasts treated in vitro, backed by a split-face clinical microneedle-patch trial over 8 weeks
- Limitation
- The dermal-density improvement is confirmed via microneedle-assisted delivery, not a passive topical cream; passive creams rely on proper transdermal carrier formulation to reach deeper dermal fibroblast A2A receptors, and this claim does not establish that a standalone passive cream reaches the same depth.
Open
Large-scale multi-center double-blind randomized clinical trials comparing the long-term standalone wrinkle-improvement speed of pure 0.04% adenosine monotherapy against 0.1% retinol over 24 weeks.
Open
How we verify The research packet's scalp hair-density claim (comparing topical adenosine to 5% minoxidil in male androgenetic alopecia) cites a source whose actual PubMed record does not support the claim as stated. The corrected citation resolves to a real, relevant randomized trial comparing 5% minoxidil and 0.75% adenosine solutions in male androgenetic alopecia, but that trial's own findings differ substantially from the packet's framing: relative hair-recovery rates showed no statistically significant difference between the two arms, no patient in either arm achieved complete recovery after six months, and only patient satisfaction -- not hair density or recovery rate -- reached statistical significance for the adenosine arm. The packet's stated sample size also does not match the real trial's reported enrollment. This record does not map that claim, its hair/scalp best-match tags, or any mechanism or FAQ text that depended on it.
Questions & related
Common questions · 자주 묻는 질문
Why is Adenosine so popular in Korean skincare?
Adenosine is officially recognized by South Korea's Ministry of Food and Drug Safety (MFDS) as a functional anti-wrinkle ingredient at 0.04% concentration. Products formulated with 0.04% adenosine can easily claim 'wrinkle improvement' benefits on packaging. Furthermore, it is exceptionally gentle and compatible with all skin types, making it a staple in K-beauty well-aging formulas.
Can Adenosine be paired with Retinol or Vitamin C?
Yes. Adenosine is non-acidic, non-irritating, and does not cause photosensitivity. It pairs seamlessly with Retinol, Vitamin C, Niacinamide, and Peptides to provide complementary anti-aging and collagen-supporting benefits without increasing barrier irritation.
The clinical recordHow it works · Forms · Manufacturing · Regulations · Study ledger · Gaps · Sources
How it works
Adenosine is an endogenous purine nucleoside that binds to cell-surface G-protein coupled adenosine A2A receptors on dermal fibroblasts. Receptor activation triggers a physiological increase in intracellular cyclic AMP (cAMP) and activates AKT kinase pathways, upregulating gene transcription and synthesis of type I and type III procollagen while suppressing collagen-degrading matrix metalloproteinases, restoring dermal structural firmness and smoothing expression lines 2,3.
- A2A Cell-Surface Receptor Activation
- AKT Kinase Signaling and Neocollagenesis
- Fli1 and CTGF Matrix Remodeling Modulation
Suppresses the constitutive collagen repressor Fli1 and induces connective tissue growth factor (CTGF), favoring extracellular matrix remodeling and dermal thickening.
What that rests on: in-vitro fibroblast molecular models
Source3
Reading the label
- Find this name
- 아데노신 (Adenosine) — Pure Adenosine, the gold-standard anti-wrinkle functional active in K-beauty.
- Read the percentage
- Under South Korea's Ministry of Food and Drug Safety (MFDS), a concentration of exactly 0.04% is the officially notified threshold to qualify for a simplified functional wrinkle-improvement notification.
- Judge production transparency
- Manufacturers disclose HPLC assay percentages, optical rotation, heavy metals, and residual solvent limits.
| Attribute | Pure Bio-Fermented Adenosine |
|---|---|
| What it is | The standard, highly stable, water-soluble active compound that penetrates the epidermis to bind cell-surface A2A adenosine receptors. |
| Official INCI | ADENOSINE |
| Where it comes from | Yeast fermentation (e.g. Saccharomyces cerevisiae or Candida famata) |
| How it is made | Produced via sustainable yeast fermentation, followed by microfiltration, crystallization, and high-purity chromatographic purification to yield white crystalline powder. |
| Gentleness | Exceptionally gentle, non-irritating, and compatible with all skin types including compromised barriers. |
How it is actually made
- Origin regions: South Korea, Japan, Germany, China
- Produced via biotechnology through the controlled yeast fermentation of Saccharomyces cerevisiae or Candida famata in nutrient glucose media. The nucleoside is isolated from fermentation broth via microfiltration, ion-exchange chromatography, crystallization, and freeze-drying to achieve high purity.
- Potency is verified by HPLC standardizing pure adenosine content to a minimum of 99.0% assay purity, with strict limits on heavy metals (<= 10 ppm) and microbiological contaminants.
- Manufacturers disclose HPLC assay percentages, optical rotation, heavy metals, and residual solvent limits.
Where the ceiling is set
South Korea
In force since 2012-02-05- The rule
- Ministry of Food and Drug Safety (MFDS) Cosmetics Safety Standards / Functional Cosmetics Notification Act
- What it allows
- Approved as an officially notified (기능성) anti-wrinkle functional ingredient at a concentration of 0.04%. Products using 0.04% adenosine qualify for simplified functional cosmetic registration for wrinkle improvement without requiring separate clinical testing.
European Union
- The rule
- EU Cosmetics Regulation (EC) No 1223/2009
- What it allows
- Not named in Annex II (prohibited) or Annex III (restricted) substances. Listed in the CosIng database under ADENOSINE with the function Skin Conditioning Agent -- a function/inventory listing, not a regulatory approval.
What the evidence rests on
Study records
Randomized, double-blind, placebo-controlled clinical trial2006
Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique
Twice-daily application of adenosine-containing cream and film for 8 weeks led to significant improvements in periorbital skin smoothness and significantly improved glabellar frown lines, measured by Fast Optical in-vivo Topometry of human Skin (FOITS), compared to placebo.
Where it falls shortEvaluated over an 8-week study duration in a female population aged 45-65; long-term structural maintenance beyond 2 months requires ongoing daily application.
Source1
In-vitro cell culture and signaling pathway analysis2014
Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3
Adenosine A2A receptor stimulation elicits a physiological cAMP increase that stimulates type I and type III collagen production via AKT signaling, independent of Smad2/3 activation.
Where it falls shortConducted in vitro on isolated cell culture monolayers, which lacks the physiological complexity and stratum corneum penetration barriers of live human skin.
Source2
Narrative scientific review2022
The possible role of the nucleoside adenosine in countering skin aging: A review
Review mapping adenosine receptor distribution in skin, establishing that A2A receptor stimulation in dermal fibroblasts drives collagen and extracellular matrix protein synthesis -- including suppression of the collagen repressor Fli1 and induction of connective tissue growth factor (CTGF) -- while A1 receptor activation in the hypodermis supports adipose tissue regulation, collectively smoothing wrinkles and restoring skin elasticity.
Where it falls shortSynthesizes data across diverse topical vehicles, dissolving microneedles, and cell culture models rather than presenting new primary data.
Source3
Randomized, split-face human clinical trial2018
Adenosine-loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration
In a split-face trial on 22 female subjects over 8 weeks, adenosine-loaded dissolving microneedle patches achieved similar or better efficacy than adenosine cream on wrinkle depth, elasticity, and hydration, and showed a significant improvement in dermal density that the passive cream arm did not.
Where it falls shortUses an invasive microneedle delivery system, which achieves higher dermal flux than standard passive topical creams; the dermal-density result is specific to microneedle-assisted delivery.
Source4
What is still missing
Large-scale multi-center double-blind randomized clinical trials comparing the long-term standalone wrinkle-improvement speed of pure 0.04% adenosine monotherapy against 0.1% retinol over 24 weeks.
The exact relative speed of standalone 0.04% adenosine vs 0.1% retinol on facial wrinkle depth over 6 months remains an approximation, as current clinical studies evaluate adenosine over 8 weeks or in combination with other anti-aging actives.
NeedsA 24-week double-blind randomized controlled trial comparing 0.04% adenosine cream vs 0.1% retinol cream vs vehicle base on 120 subjects with moderate facial wrinkles.
The research packet's scalp hair-density claim (comparing topical adenosine to 5% minoxidil in male androgenetic alopecia) cites a source whose actual PubMed record does not support the claim as stated. The corrected citation resolves to a real, relevant randomized trial comparing 5% minoxidil and 0.75% adenosine solutions in male androgenetic alopecia, but that trial's own findings differ substantially from the packet's framing: relative hair-recovery rates showed no statistically significant difference between the two arms, no patient in either arm achieved complete recovery after six months, and only patient satisfaction -- not hair density or recovery rate -- reached statistical significance for the adenosine arm. The packet's stated sample size also does not match the real trial's reported enrollment. This record does not map that claim, its hair/scalp best-match tags, or any mechanism or FAQ text that depended on it.
This record cannot state that topical adenosine increases scalp hair density, thickens hair shaft caliber, or performs comparably to 5% minoxidil for androgenetic alopecia. The A2A-receptor collagen-synthesis mechanism remains supported for facial/dermal use, but is not extended to a scalp hair-growth outcome.
NeedsAn independent clinical trial of topical adenosine at a stated concentration, measuring hair density or hair-regrowth outcomes against a placebo or active comparator, whose published finding matches the outcome claimed -- a statistically significant improvement in hair density or recovery rate, not only in a secondary patient-satisfaction measure.
Sources on file
- Abella ML. Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique. Int J Cosmet Sci (2006)(opens in a new tab)
- Perez-Aso M, Fernandez P, Mediero A, Chan ES, Cronstein BN. Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3. FASEB J (2014)(opens in a new tab)
- Marucci G, Buccioni M, Varlaro V, Volpini R, Amenta F. The possible role of the nucleoside adenosine in countering skin aging: A review. BioFactors (2022)(opens in a new tab)
- Kang G, Tu TNT, Kim S, Yang H, Jang M, Jo D, Ryu J, Baek J, Jung H. Adenosine-loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration. Int J Cosmet Sci (2018)(opens in a new tab)
- Bozzo, Chua-Gocheco & Einarson. Can Fam Physician (2011)(opens in a new tab)